Review



deidentified clinformatics data mart database  (Optum Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Optum Inc deidentified clinformatics data mart database
    Deidentified Clinformatics Data Mart Database, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deidentified clinformatics data mart database/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    deidentified clinformatics data mart database - by Bioz Stars, 2026-04
    90/100 stars

    Images



    Similar Products

    90
    Optum Inc deidentified clinformatics data mart database
    Deidentified Clinformatics Data Mart Database, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deidentified clinformatics data mart database/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    deidentified clinformatics data mart database - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Optum Inc de-identified clinformatics ® data mart
    De Identified Clinformatics ® Data Mart, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics ® data mart/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics ® data mart - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Optum Inc optum’s de-identified clinformatics® data mart database (clinformatics)
    Optum’s De Identified Clinformatics® Data Mart Database (Clinformatics), supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/optum’s de-identified clinformatics® data mart database (clinformatics)/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    optum’s de-identified clinformatics® data mart database (clinformatics) - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Optum Inc clinformatics® data mart database
    Clinformatics® Data Mart Database, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clinformatics® data mart database/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    clinformatics® data mart database - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Optum Inc clinformatics data mart (cdm)-standard view with mortality plus race (dodr) database
    Clinformatics Data Mart (Cdm) Standard View With Mortality Plus Race (Dodr) Database, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clinformatics data mart (cdm)-standard view with mortality plus race (dodr) database/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    clinformatics data mart (cdm)-standard view with mortality plus race (dodr) database - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Optum Inc clinformatics data mart database
    Clinformatics Data Mart Database, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clinformatics data mart database/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    clinformatics data mart database - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Optum Inc clinformatics data mart
    Clinformatics Data Mart, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clinformatics data mart/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    clinformatics data mart - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Optum Inc de-identified clinformatics® data mart
    De Identified Clinformatics® Data Mart, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics® data mart/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics® data mart - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Optum Inc de-identified clinformatics data mart
    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified <t>Clinformatics</t> ® Data Mart; US, United States.
    De Identified Clinformatics Data Mart, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics data mart/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics data mart - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Optum Inc de-identified clinformatics® data mart (optum cdm)
    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified <t>Clinformatics</t> ® Data Mart; US, United States.
    De Identified Clinformatics® Data Mart (Optum Cdm), supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics® data mart (optum cdm)/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics® data mart (optum cdm) - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US, United States.

    Journal: PLOS One

    Article Title: Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023

    doi: 10.1371/journal.pone.0323843

    Figure Lengend Snippet: AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US, United States.

    Article Snippet: This retrospective study aims to update the epidemiology of AIHA and CAD in the US from 2016 to 2023 by separately analyzing administrative claims data from Optum’s de-identified Clinformatics ® Data Mart (Optum CDM), Inovalon’s Medical Outcomes Research for Effectiveness and Economics (MORE 2 ) Registry, and Medicare Fee for Service (FFS).

    Techniques:

    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart. Note: The incidence and prevalence numbers for CAD were relatively lower; hence, these numbers were not shown on the graphs.

    Journal: PLOS One

    Article Title: Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023

    doi: 10.1371/journal.pone.0323843

    Figure Lengend Snippet: AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart. Note: The incidence and prevalence numbers for CAD were relatively lower; hence, these numbers were not shown on the graphs.

    Article Snippet: This retrospective study aims to update the epidemiology of AIHA and CAD in the US from 2016 to 2023 by separately analyzing administrative claims data from Optum’s de-identified Clinformatics ® Data Mart (Optum CDM), Inovalon’s Medical Outcomes Research for Effectiveness and Economics (MORE 2 ) Registry, and Medicare Fee for Service (FFS).

    Techniques:

    (A) Optum CDM (2023), (B) MORE 2 Registry (2022), and (C) Medicare FFS (2021). AIHA, autoimmune hemolytic anemia; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US United States. AK, Alaska; AL, Alabama; AR, Arkansas; AZ, Arizona; CA, California; CO, Colorado; CT, Connecticut; DC, District of Columbia; DE, Delaware; FL, Florida; GA, Georgia; HI, Hawaii; IA, Iowa; ID, Idaho; IL, Illinois; IN, Indiana; KS, Kansas; KY, Kentucky; LA, Louisiana; MA, Massachusetts; MD, Maryland; ME, Maine; MI, Michigan; MN, Minnesota; MO, Missouri; MS, Mississippi; MT, Montana; NC, North Carolina; ND, North Dakota; NE, Nebraska; NH, New Hampshire; NJ, New Jersey; NM, New Mexico; NV, Nevada; NY, New York; OH, Ohio; OK, Oklahoma; OR, Oregon; PA, Pennsylvania; RI, Rhode Island; SC, South Carolina; SD, South Dakota; TN, Tennessee; TX, Texas; UT, Utah; VA, Virginia; VT, Vermont; WA, Washington; WI, Wisconsin; WV, West Virginia; WY, Wyoming.

    Journal: PLOS One

    Article Title: Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023

    doi: 10.1371/journal.pone.0323843

    Figure Lengend Snippet: (A) Optum CDM (2023), (B) MORE 2 Registry (2022), and (C) Medicare FFS (2021). AIHA, autoimmune hemolytic anemia; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US United States. AK, Alaska; AL, Alabama; AR, Arkansas; AZ, Arizona; CA, California; CO, Colorado; CT, Connecticut; DC, District of Columbia; DE, Delaware; FL, Florida; GA, Georgia; HI, Hawaii; IA, Iowa; ID, Idaho; IL, Illinois; IN, Indiana; KS, Kansas; KY, Kentucky; LA, Louisiana; MA, Massachusetts; MD, Maryland; ME, Maine; MI, Michigan; MN, Minnesota; MO, Missouri; MS, Mississippi; MT, Montana; NC, North Carolina; ND, North Dakota; NE, Nebraska; NH, New Hampshire; NJ, New Jersey; NM, New Mexico; NV, Nevada; NY, New York; OH, Ohio; OK, Oklahoma; OR, Oregon; PA, Pennsylvania; RI, Rhode Island; SC, South Carolina; SD, South Dakota; TN, Tennessee; TX, Texas; UT, Utah; VA, Virginia; VT, Vermont; WA, Washington; WI, Wisconsin; WV, West Virginia; WY, Wyoming.

    Article Snippet: This retrospective study aims to update the epidemiology of AIHA and CAD in the US from 2016 to 2023 by separately analyzing administrative claims data from Optum’s de-identified Clinformatics ® Data Mart (Optum CDM), Inovalon’s Medical Outcomes Research for Effectiveness and Economics (MORE 2 ) Registry, and Medicare Fee for Service (FFS).

    Techniques:

    (A) Optum CDM (2023), (B) MORE 2 Registry (2022), and (C) Medicare FFS (2021). CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US, United States. AK, Alaska; AL, Alabama; AR, Arkansas; AZ, Arizona; CA, California; CO, Colorado; CT, Connecticut; DC, District of Columbia; DE, Delaware; FL, Florida; GA, Georgia; HI, Hawaii; IA, Iowa; ID, Idaho; IL, Illinois; IN, Indiana; KS, Kansas; KY, Kentucky; LA, Louisiana; MA, Massachusetts; MD, Maryland; ME, Maine; MI, Michigan; MN, Minnesota; MO, Missouri; MS, Mississippi; MT, Montana; NC, North Carolina; ND, North Dakota; NE, Nebraska; NH, New Hampshire; NJ, New Jersey; NM, New Mexico; NV, Nevada; NY, New York; OH, Ohio; OK, Oklahoma; OR, Oregon; PA, Pennsylvania; RI, Rhode Island; SC, South Carolina; SD, South Dakota; TN, Tennessee; TX, Texas; UT, Utah; VA, Virginia; VT, Vermont; WA, Washington; WI, Wisconsin; WV, West Virginia; WY, Wyoming.

    Journal: PLOS One

    Article Title: Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023

    doi: 10.1371/journal.pone.0323843

    Figure Lengend Snippet: (A) Optum CDM (2023), (B) MORE 2 Registry (2022), and (C) Medicare FFS (2021). CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US, United States. AK, Alaska; AL, Alabama; AR, Arkansas; AZ, Arizona; CA, California; CO, Colorado; CT, Connecticut; DC, District of Columbia; DE, Delaware; FL, Florida; GA, Georgia; HI, Hawaii; IA, Iowa; ID, Idaho; IL, Illinois; IN, Indiana; KS, Kansas; KY, Kentucky; LA, Louisiana; MA, Massachusetts; MD, Maryland; ME, Maine; MI, Michigan; MN, Minnesota; MO, Missouri; MS, Mississippi; MT, Montana; NC, North Carolina; ND, North Dakota; NE, Nebraska; NH, New Hampshire; NJ, New Jersey; NM, New Mexico; NV, Nevada; NY, New York; OH, Ohio; OK, Oklahoma; OR, Oregon; PA, Pennsylvania; RI, Rhode Island; SC, South Carolina; SD, South Dakota; TN, Tennessee; TX, Texas; UT, Utah; VA, Virginia; VT, Vermont; WA, Washington; WI, Wisconsin; WV, West Virginia; WY, Wyoming.

    Article Snippet: This retrospective study aims to update the epidemiology of AIHA and CAD in the US from 2016 to 2023 by separately analyzing administrative claims data from Optum’s de-identified Clinformatics ® Data Mart (Optum CDM), Inovalon’s Medical Outcomes Research for Effectiveness and Economics (MORE 2 ) Registry, and Medicare Fee for Service (FFS).

    Techniques:

    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart.

    Journal: PLOS One

    Article Title: Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023

    doi: 10.1371/journal.pone.0323843

    Figure Lengend Snippet: AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart.

    Article Snippet: This retrospective study aims to update the epidemiology of AIHA and CAD in the US from 2016 to 2023 by separately analyzing administrative claims data from Optum’s de-identified Clinformatics ® Data Mart (Optum CDM), Inovalon’s Medical Outcomes Research for Effectiveness and Economics (MORE 2 ) Registry, and Medicare Fee for Service (FFS).

    Techniques: